Literature DB >> 551622

Residual shunt infection in a program aimed at its prevention.

K Welch.   

Abstract

Measures designed to prevent infection after cerebrospinal fluid shunts were described earlier. These include refinements in technique, postponement of operations when there is an actual or threatened leak of cerebrospinal fluid and the use of topical, systemic and intraventricular antibiotics. Six hundred and twenty-four operations in 404 patients, carried out after instituting these precautions were complicated by 13 new infections (2.1%) while in 5 instances (.8%) infection complicated a procedure conducted in the presence of a pre-existant but unrecognized infection. In almost every case the pathogenesis of new infection was clear. The circumstances suggest that some of the residual infections, both new and renewed, might by preventable.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 551622

Source DB:  PubMed          Journal:  Z Kinderchir Grenzgeb        ISSN: 0044-2909


  7 in total

Review 1.  Evidence-based interventions to reduce shunt infections: a systematic review.

Authors:  Nehaw Sarmey; Varun R Kshettry; Michael F Shriver; Ghaith Habboub; Andre G Machado; Robert J Weil
Journal:  Childs Nerv Syst       Date:  2015-02-17       Impact factor: 1.475

2.  Postoperative infection in shunts for hydrocephalus: are prophylactic antibiotics necessary?

Authors:  Z B Tabara
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

3.  Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances.

Authors:  R Bayston; R D Milner
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

4.  Long-term mortality rates in pediatric hydrocephalus-a retrospective single-center study.

Authors:  Matthias Gmeiner; Helga Wagner; Christoph Zacherl; Petra Polanski; Christian Auer; Willem J R van Ouwerkerk; Kurt Holl
Journal:  Childs Nerv Syst       Date:  2016-10-20       Impact factor: 1.475

Review 5.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

6.  Zero tolerance to shunt infections: can it be achieved?

Authors:  M S Choksey; I A Malik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

7.  A randomized controlled trial of perioperative rifampin/trimethoprim in cerebrospinal fluid shunt surgery.

Authors:  B C Walters; L Goumnerova; H J Hoffman; E B Hendrick; R P Humphreys; C Levinton
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.